| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $140.5M | $119.8M | $119.1M |
| YoY Revenue Growth % | — | +0.6% | — |
| Gross Profit | $94.9M | $82.1M | — |
| Gross Margin % | 67.5% | 68.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$8.4M | -$10.7M | -$3.0M |
| Operating Margin % | -6.0% | -9.0% | -2.5% |
| Net Income (GAAP) | -$13.1M | -$11.8M | -$9.2M |
| EBITDA (Normalized) | -$7.8M | -$10.2M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $22.2M | $9.4M | $18.9M |
| Capital Expenditures (CapEx) | $787.0K | $692.0K | — |
| Free Cash Flow (FCF) | $21.4M | $8.7M | $18.9M |
| FCF Margin % | 15.2% | 7.3% | 15.9% |
| Return on Invested Capital (ROIC %) | -2.8% | -4.7% | — |
| Cash & Short-Term Equivalents | $25.2M | $21.4M | — |
| Total Debt (Short + Long Term) | $63.3M | $5.7M | — |
| Total Stockholders' Equity | $197.8M | $197.3M | — |